![]() | ![]() |
Formats:
|
||||||||||||
Copyright © 2001, The National Academy of Sciences Immunology A shark antibody heavy chain encoded by a nonsomatically
rearranged VDJ is preferentially expressed in early development and
is convergent with mammalian IgG *Department of Microbiology and Immunology, University of Miami School of Medicine, P.O. Box 016960 (R-138), Miami, FL 33101; †Department of Microbiology and Immunology, University of Maryland at Baltimore, Baltimore, MD 21201; ‡Basel Institute for Immunology, Basel 4005, Switzerland; §The Scripps Research Institute, La Jolla, CA 92037; and ¶Moss Landing Marine Labs, Moss Landing, CA 95039 ‖To whom reprint requests should be addressed at: BRB
13-009, 655 West Baltimore Street, Department of Microbiology and
Immunology, University of Maryland, Baltimore, MD 21201. E-mail:
MFlajnik/at/som.umaryland.edu. Edited by Michael Potter, National Institutes of Health,
Bethesda, MD, and approved December 15, 2000 Received August 3, 2000. This article has been cited by other articles in PMC.Abstract In most vertebrate embryos and neonates studied to date unique
antigen receptors (antibodies and T cell receptors) are expressed that
possess a limited immune repertoire. We have isolated a subclass of
IgM, IgM1gj, from the nurse shark Ginglymostoma
cirratum that is preferentially expressed in neonates. The
variable (V) region gene encoding the heavy (H) chain underwent V-D-J
rearrangement in germ cells (“germline-joined”). Such H chain V
genes were discovered over 10 years ago in sharks but until now were
not shown to be expressed at appreciable levels; we find expression of
H1gj in primary and secondary lymphoid tissues early in
life, but in adults only in primary lymphoid tissue, which is
identified in this work as the epigonal organ. H1gj chain
associates covalently with light (L) chains and is most similar in
sequence to IgM H chains, but like mammalian IgG has three rather than
the four IgM constant domains; deletion of the ancestral IgM C2 domain
thus defines both IgG and IgM1gj. Because sharks are the
members of the oldest vertebrate class known to possess antibodies,
unique or specialized antibodies expressed early in ontogeny in sharks
and other vertebrates were likely present at the inception of the
adaptive immune system. In mammals, expressed Ig and
T cell receptors (TCR) of fetuses and newborns are qualitatively
different from those of adults. For Ig, a few particular variable (V)
regions are expressed by an early subset of developing B cells (B1
cells) that are later supplanted by new precursors with a diverse
repertoire (1). T cell precursors bearing γ/δ TCR with highly
restricted repertoires develop in the fetal thymus and then are also
replaced in this primary lymphoid tissue by conventional, major
histocompatibility complex (MHC)-restricted α/β T cells
(2). Lymphocytes bearing such “innate” receptors are produced
early in ontogeny when little diversity is generated as a consequence
of gene (V-D-J or V-J) rearrangement (3–5). In addition, innate cells
can self-renew and are found in the peritoneal cavity (B1 cells in
mice; ref. 6) and epithelial surfaces (γ/δ T cells; ref. 7),
where they are presumed to serve specialized functions. The early
appearance of innate lymphocytes, serving perhaps as a first line of
defense, and the late appearance of “adaptive” B and T cells with
great antigen receptor diversity and residing in secondary lymphoid
tissues are the foundation of the “Layering Hypothesis” of the
immune system proposed by the Herzenbergs (8). Elasmobranchs (sharks, skate, and rays) are members of the oldest
vertebrate taxon known to possess an adaptive immune system grounded on
Ig, TCR, and the MHC (9). There are at least three Ig classes in
elasmobranchs: IgM (10), IgNAR (11), and IgW (12–15). IgM is the
orthologue of the IgM identified in all other vertebrates and is the
best studied class in elasmobranchs; it is found in both monomeric (7S)
and multimeric (19S) forms and comprises about half of the serum
protein in adults (16). Neonatal nurse sharks (Ginglymostoma
cirratum) were shown to have very low serum levels of IgM at birth
and required over 1 month post partum to approach adult-like
levels (17). Their total serum protein, however, was the same as in
adults, indicating that other unidentified neonatal proteins were
present. Nurse sharks are ovoviviparous, developing within an egg case
in the uterus, so there is no maternal Ig transfer as in mammals
although there might be transfer to embryos from the yolk (18). All elasmobranch Ig heavy (H) and light (L) chain genes are in the
“cluster” configuration, with each H chain cluster containing one
variable (V), 2–3 diversity (D), one joining (J), and several constant
(C) exons (19). There are estimated to be up to 200 IgM H chain
clusters in the horn shark (Heterodontus francisci; refs. 20
and 21). Most expressed H chains are encoded by clusters that rearrange
the V, D, and J genes in what is inferred to be the typical mammalian
fashion; in contrast, up to 50% of the clusters have V, D, and J genes
that are either partially or wholly pre-rearranged
(“germline-joined”), and these genes are not expressed at
appreciable levels, i.e., detected by Northern blotting or even as
cDNAs from adult spleen libraries (22). However, such germline-joined
clusters were theorized to be expressed early in ontogeny and/or in
specialized tissues; it was also suggested that they could provide a
selective advantage by perpetuating germline specificities and thus be
used for specific functions (22–26). Along with Ig, TCR, and MHC, cartilaginous fish are the oldest
vertebrates to have both primary (hematopoietic cell-producing) and
secondary (immune response-generating) lymphoid tissues (27, 28). Based
upon morphological studies, the putative bone marrow equivalent is the
epigonal organ, which is physically associated with gonadal tissue
throughout life, or the Leydig organ, attached to the outer wall of the
esophagus. Depending on the particular species examined, either one or
both of these tissues is present and they have the same basic
organization: >50% of the cells are myeloid but lymphoid and
Ig-secretory cells have also been observed (29). The spleen is the only
elasmobranch secondary lymphoid tissue with defined accumulations of
mature lymphoid cells; it has distinct white and red pulp
regions but no marginal zone separating the two. The white pulp areas
contain predominantly lymphocytes of different sizes and a few mature
and developing secretory B cells. The red pulp contains erythrocytes,
leukocytes of many types (including secretory B cells), and venous
sinuses (ref. 27; L.L.R. and M.F.F., unpublished results). While carrying out studies of the developmental regulation of IgM and
IgNAR expression, we identified serendipitously a subclass of IgM
expressed during the early life of nurse sharks. As reported here, its
expression and gene structure conform to speculations tendered above
for the function of cartilaginous fish germline-joined Ig genes, and
reveal that antigen receptors expressed early in development are
different from those in adult life in a wide range of vertebrates.
Furthermore, its expression led us to reexamine, with molecular means,
the hypothesis that the epigonal organ serves as a primary lymphoid
tissue in elasmobranchs. Materials and Methods Animals. Nurse shark (G. cirratum) pups were delivered by Caesarian
section from three females as described (30). Because there is no table
of nurse shark development, we do not know the precise ages of these
animals, but offspring were collected in October/November in South
Florida when females drop their pups (mating in June/July). The pups
were maintained in aerated seawater and fed seafood twice a week. Blood
was obtained (16) and plasma was collected and either used immediately
for biochemical studies or frozen in aliquots at −20°C. Pup Spleen and Epigonal Organ cDNA Libraries and Genomic Cosmid
Library. Two newborn nurse shark pups were anesthetized in MS-222. Tissues were
collected, and total RNA was prepared per the TRIzol RNA isolation
protocol (GIBCO/BRL). mRNA was prepared per Ambion (Austin, TX)
Poly(A) Pure kit. The cDNA libraries were constructed per Stratagene
ZAP-cDNA library kit using 5 μg mRNA pooled from each tissue. The
cosmid library was constructed commercially by using erythrocyte
genomic DNA from one adult nurse shark per Stratagene SuperCos 1 Cosmid
library. Whole blood was centrifuged, and the peripheral blood
lymphocyte buffy coat was discarded. The erythrocyte pellet was
subjected to two rounds of Ficoll gradient centrifugation to rigorously
deplete all lymphocytes. The spleen and epigonal libraries were
screened under both high and low stringency conditions as described
(31) with the conventional IgM VH probe (32). Probes. Splenic or thymic cDNA or plasmid DNA containing cloned cDNA inserts
were used as templates for PCR amplification of all probes as described
(30). Oligo(dT)-primed cDNA was made from 5 μg nurse shark total RNA
thymus and spleen by using GIBCO/BRL Superscript First Strand cDNA
Synthesis kit. The probes were the following: conventional IgM V (no.
M92851, nucleotides 1–477); IgM1gj V and CH1
(no. AF327520, see Fig. Fig.22
Southern and Northern Blots. Southern blots were done under low or high stringency conditions (34).
Five micrograms of nurse shark pup or adult genomic DNA was digested
for 1.5 days with various enzymes. For Northerns (31), gels were loaded
with 20 μg total RNA or 4 μg mRNA per lane. The labeled probes were
hybridized with filters for a minimum of 20 h at 42°C and then
washed under high or low stringency conditions (34). Monoclonal Antibodies, Immunoprecipitation, and Metabolic Labeling. Monoclonal antibodies (mAbs) specific for nurse shark IgM were made as
described (11, 35, 36). CB5, CB16, and LK45 recognize both the 19S and
7S forms of IgM, GA15 prefers 7S to 19S, and GA16 prefers 19S. LK14
recognizes both 19S and 7S IgM via an L chain epitope. NART1 is
specific for the IgNAR C terminus. NK11 binds a shark cell surface
protein not present in plasma and was used as a negative control
(E.C.M. and M.F.F., unpublished results). JC4 is specific for shark J
chains (V. S. Hohman, A. S. Greenberg, L.L.R., D.A., M.F.F.,
and L. A. Steiner, unpublished results). Nurse shark plasma
proteins were labeled with 125I by using the
chloramine T method (37). Radio-iodinated plasma (1–4 μl containing
106 cpm) was incubated with 100 μl neat mAb
supernatants overnight at 4°C, and the complexes were captured with
protein-G bead adsorbents (11). SDS/PAGE on 5% (nonreducing) or 9%
(reducing) gels was done as described (11, 14). Biomax MR film (Kodak)
was used for autoradiography. For metabolic labeling, nurse sharks were
euthanized, and single cell suspensions of spleen and epigonal organ
were prepared. Cells were labeled overnight with
35S Trans (radiolabeled methionine and cysteine,
ICN) as described (14). Supernatants containing labeled secreted Igs
were collected and immunoprecipitated with mAbs as described above for
plasma. Protein Sequencing. IgM1gj was immunopurified on a protein-G-mAb GA15
affinity column as described (36), separated on a 13% SDS/PAGE gel
under reducing conditions, and electroblotted to poly(vinylidene
difluoride) membrane (Immobilon-Psq, Millipore)
for 2 h at 250 mA constant current in 10 mM CAPS
(3-cyclohexylamino-1-propanesulfonic acid), pH 11/10% methanol.
Proteins were stained with 0.1% (wt/vol) Amido Black 1oB (Bio-Rad)
in methanol/acetic acid/water (40:10:50) and then destained with
methanol/acetic acid (50:10). Protein bands at 55.7 kDa and 53 kDa
(see Fig. Fig.1)1
Results IgM1gj Predominates During Early Development. While examining the ontogeny of expression of known secreted nurse
shark Ig classes, we immunoprecipitated a new form of Ig,
IgM1gj,** from
radio-iodinated plasma proteins of neonates with a subset of our mAbs
specific for conventional IgM (e.g., lane(s) 3 in Fig.
Fig.11
IgM1gj protein is expressed in adults, but
attempts to isolate it from adult plasma were unsuccessful because of
the large amounts of conventional IgM present at maturity (16).
However, metabolic labeling of cells from adult epigonal organ and
spleen clearly showed IgM1gj protein produced at
appreciable levels relative to conventional IgM only in the epigonal
organ (Fig. (Fig.11 The H1gj V Gene Is Germline Joined. IgM1gj was affinity purified with the GA15 mAb
from neonatal plasma, and H1gj was sequenced.
Both closely spaced bands described above at ≈56 and 53 kDa (Fig. (Fig.1)
1 To prove that H1gj V region was germline joined,
we screened a nurse shark genomic cosmid library, prepared from
erythrocyte DNA of one shark from which all lymphocytes were rigorously
depleted, with the H1gj V and
CH1 cDNA probes under high stringency conditions.
Isolated clones were sequenced and revealed the following:
(i) the leader exon is split by an intron that is found in
all IgV genes (39), indicating that H1gj is
encoded by a typical V gene (not shown), and (ii) the
VH1gj gene is germline joined with a V-D-J join
that precisely matches the sequences of the cDNA clones (Fig.
(Fig.22 In conventional IgM of the horn shark and ratfish (Hydrolagus
collei), the rearrangement join generally includes two D segments,
designated D1 and D2; VH1gj CDR3 is short, in
part because it appears to use only one D gene (D2, deduced from horn
shark genomic sequences; ref. 22; Fig. Fig.22 The V domain framework regions (FR) 1–3 are most similar to horn shark
IgM VH [65% amino acid (aa) identity] but only
55% identical to any particular nurse shark IgM
VH. Phylogenetic analysis of VH1gj
indicates that it is a new nurse shark V family having only 70%
nucleotide identity and less than 70% aa identity with conventional
IgM VH (38 and see below). Besides the short
CDR3, the other conspicuous feature is the paucity of serines usually
found in a high percentage of CDR1 and CDR2 aa residues in conventional
IgM; there is an average of six serines in CDR1 and CDR2 from horn
shark (22), sandbar shark (Carcharhinus plumbeus, ref. 40),
and nurse shark (32) H chain sequences (Fig. (Fig.22 Features of the H1gj C Domains, Especially the Lack of
a CH2 Domain Exon in the Gene Clusters. The CH1 domain of IgM1gj
lacks the cysteine (cys) commonly used for L chain association (38) and
is substituted by asparagine (bold, asterisk in Fig.
Fig.22 IgM1gj Is a Single Copy Gene. Southern blot analysis was done to determine the number of
VH-1gj and CH1-1gj genes.
V1gj and CH1-1gj exons
apparently hybridize to only one cluster under high stringency
conditions, indicating that there is only one member in this new family
(Fig. (Fig.3);3
Newborn Expression and Maintenance in Adults. Because IgM1gj protein was shown to be secreted
from neonatal spleen and from both neonatal and adult epigonal organs,
a Northern blot analysis was done to ascertain which pup and adult
tissues expressed IgM1gj. The relative mRNA
expression of IgM1gj, IgM, RAG1, TdT, and the
positive control nucleoside diphosphate kinase (NDPK) is displayed in
Fig. Fig.4.4 RAG1 expression is continuous in the thymus and epigonal organ
throughout life (Fig. (Fig.44 Discussion We have discovered an IgM subclass in the nurse shark,
IgM1gj, which is expressed predominantly in
neonatal sharks. The mAbs crossreacting with
IgM1gj also recognize 7S and/or 19S IgM;
however, neonatal IgM levels are much lower than in adults, which
“allowed” the identification of IgM1gj. As
pups mature, large amounts of IgM are produced that dilute the
IgM1gj, so serum levels of the latter appear to
decrease. It is possible that, like innate lineages of mammalian
lymphocytes, the IgM1gj cell lineage develops at
the inception of the immune system and undergoes self-renewal in the
epigonal organ throughout life. Another, equally likely possibility is
that IgM1gj cells are continually produced from a
small number of stable precursors in the epigonal organ. Previous studies in the horn shark reported a very large number of
germline-joined IgH genes, but apparently no expression of them (22,
23). Ratfish germline-joined H chain clusters were also isolated, and
their expression could be detected only by a sensitive reverse
transcription-PCR procedure (42). One hypothesis to account for such
low-to-undetectable expression in adult spleen was that some of these
prejoined clusters encoding proteins with specific functions might be
expressed in a tissue-specific and/or developmentally controlled
manner; this hypothesis is fulfilled from our study of
IgM1gj, at least for the restricted tissue
expression and ontogenetic appearance. We have detected a similar mode
of expression of an IgNAR partially germline-joined cluster (M.D. and
M.F.F., unpublished results) and L chain clusters (in collaboration
with E. Hsu, ref. 25), and we predict this expression of such clusters
will be the rule in all elasmobranchs when there is a mixture of joined
and unjoined genes of particular antigen receptor families. It may be
that the germline-joined clusters have a transcriptional advantage
early in development, and that some clusters have been selected for
particular roles before development of the adaptive response (25,
26). It must also be noted that, in certain L chain families, the
clusters are entirely germline joined in some elasmobranch species and
are expressed throughout life (43–45). It is very likely that the H1gj gene was derived
from a RAG-mediated rearrangement event in the germline, an activity
that was inferred from many previous studies (reviewed in ref. 23), and
recently proven for shark L chains (25). Proposed precise cleavages at
two heptamer/coding end junctions, and the potential P nucleotide
addition strongly suggest that the rearrangement was RAG mediated (Fig.
(Fig.22 IgM1gj is similar to mammalian IgG by having the
domain homologous to IgM CH2 deleted over
evolutionary time in both molecules (38). Such deletions must have
occurred independently in genes ancestral to shark
IgM1gj and to mammalian IgG C region genes; based
on sequence similarity to other Igs, the IgM1gj V
family seems to have emerged some time near the divergence of nurse and
horn sharks 120–160 million years ago (see supplemental data). Its
smaller size may allow for easier passage into tissue spaces compared
with monomeric IgM; furthermore, like a mutant mammalian IgG that lacks
a hinge region (47), IgM1gj may be unable to
interact with complement, thus limiting inflammatory responses in
developing sharks. Like human IgG1 (48), the
disulfide bridge bonding H and L chains has been altered but in a way
difficult to predict, which might induce an atypical conformation of
the VH/VL pair. Much work is still needed as well to establish the epigonal organ as
the elasmobranch bone marrow equivalent, but the new evidence of RAG
and TdT expression only in this tissue and thymus throughout life is
compelling. Such expression of enzymes involved in rearrangement,
morphological studies demonstrating lymphoid aggregates (29), and the
fact that all species of cartilaginous fish have similar tissues
regardless of their location within the body (28, 29), strongly suggest
that epigonal/Leydig organ is a primary lymphoid tissue. Furthermore,
the data in Fig. Fig.44 The discovery of Igs expressed early in development derived from
germline-joined genes fits well with Herzenberg's Layering Hypothesis
(8). The dichotomy between antigen receptors expressed early and late
in development has now been described in mammals, frogs (49), and
cartilaginous fish, and this basic truth should herald a rich area of
future research (50). In particular, the elasmobranchs, with their
germline-joined gene clusters, may provide a wealth of information on
this topic; the fact that we and our colleagues have detected at least
one joined cluster expressed early in development for each antibody
class tested (and indeed only one for the IgM class in nurse sharks,
Fig. Fig.3)3 Supplemental Data
Acknowledgments We thank Louis Du Pasquier and Ellen Hsu for general discussion,
Becky Lohr for technical support, David Nemazee and Ferenc Livak for
critical reading of the manuscript, an anonymous reviewer for suggested
modifications, and Robyn Stanfield and Ian Wilson for discussion of the
IgM1gj structure. The work was supported by National
Institutes of Health Grant RR06603. Abbreviations Footnotes This paper was submitted
directly (Track II) to the
PNAS office. **IgM1gj is so-named because it is related to
conventional IgM; 1 refers to the 1st IgM gene expressed in ontogeny
and expression in primary lymphoid tissue; and gj signifies that the
variable gene is germline joined. References 1. Perlmutter R M, Kearney J F, Chang S P, Hood L E. Science. 1985;227:1597–1601. [PubMed] 2. Itohara S, Nakanishi N, Kanagawa O, Kubo R, Tonegawa S. Proc Natl Acad Sci USA. 1989;86:5094–5098. [PubMed] 3. Feeney A J. J Exp Med. 1990;172:1377–1390. [PubMed] 4. Schwager J, Buerckert N, Courtet M, Du Pasquier L. EMBO J. 1991;10:2461–2470. [PubMed] 5. Lee A, Hsu E. J Immunol. 1994;152:4500–4507. [PubMed] 6. Herzenberg L A, Kantor A B, Herzenberg L A. Ann NY Acad Sci. 1992;651:1–9. [PubMed] 7. Chien Y-H, Jores R, Crowley M P. Annu Rev Immunol. 1996;14:511–532. [PubMed] 8. Herzenberg L A, Herzenberg L A. Cell. 1989;59:953–954. [PubMed] 9. Flajnik M F, Rumfelt L L. Curr Top Microbiol Immunol. 2000;248:249–270. [PubMed] 10. Marchalonis J, Edelman G M. J Exp Med. 1965;122:601–618. [PubMed] 11. Greenberg A S, Avila D, Hughes M, Hughes A, McKinney E C, Flajnik M F. Nature (London). 1995;374:168–173. [PubMed] 12. Harding F A, Amemiya C T, Litman R T, Cohen N, Litman G W. Nucleic Acids Res. 1990a;18:6369–6376. [PubMed] 13. Bernstein R M, Schluter S F, Shen S, Marchalonis J J. Proc Natl Acad Sci USA. 1996;93:3289–3293. [PubMed] 14. Greenberg A S, Hughes A L, Guo J, Avila D, McKinney E C, Flajnik M F. Eur J Immunol. 1996;26:1123–1129. [PubMed] 15. Anderson M K, Strong S J, Litman R T, Luer C A, Amemiya C T, Rast J P, Litman G W. Immunogenetics. 1999;49:56–67. [PubMed] 16. Clem L W, DeBoutaud F, Sigel M M. J Immunol. 1967;99:1226–1235. [PubMed] 17. Fidler J E, Clem L W, Small P A. Comp Biochem Physiol. 1969;31:365–371. [PubMed] 18. Hamlett W C, Koob T J. In: Sharks, Skates, and Rays: The Biology of Elasmobranch Fishes. Hamlett W C, editor. Baltimore: Johns Hopkins Univ. Press; 1999. pp. 398–443. 19. Hinds K R, Litman G W. Nature (London). 1986;320:546–549. [PubMed] 20. Kokubu F, Hinds K, Litman R, Shamblott M J, Litman G W. Proc Natl Acad Sci USA. 1987;84:5868–5872. [PubMed] 21. Kokubu F, Hinds K, Litman R, Shamblott M J, Litman G W. EMBO J. 1988a;7:1979–1988. [PubMed] 22. Kokubu F, Litman R T, Shamblott M J, Hinds K, Litman G W. EMBO J. 1988b;7:3413–3422. [PubMed] 23. Yoder J A, Litman G W. Curr Top Microbiol Immunol. 2000;248:271–282. [PubMed] 24. Lohr R L. Thesis. Wilmington: University of North Carolina; 1998. 25. Lee S S, Fitch D, Flajnik M F, Hsu E. J Exp Med. 2000;191:1637–1648. [PubMed] 26. Lewis S M, Wu G E. J Exp Med. 2000;191:1631–1635. [PubMed] 27. Zapata A G, Torroba M, Sacedón R, Varas A, Vicente A. J Exp Zool. 1996;275:125–143. 28. Matthews L H. Philos Trans R Soc London. 1950;234:248–316. 29. Fange R, Pulsford A. Cell Tissue Res. 1983;230:337–351. [PubMed] 30. Ohta Y, Okamura K, McKinney E C, Bartl S, Hashimoto K, Flajnik M F. Proc Natl Acad Sci USA. 2000;97:4712–4717. [PubMed] 31. Bartl S, Baish M A, Flajnik M F, Ohta Y. J Immunol. 1997;159:6097–6104. [PubMed] 32. Vazquez M, Mizuki N, Flajnik M F, McKinney E C, Kasahara M. Mol Immunol. 1992;29:1157–1158. [PubMed] 33. Kasahara M, Canel C, McKinney E C, Flajnik M F. In: NATO ASI Series: Molecular Evolution of the Major Histocompatibility Complex. Klein J, Klein D, editors. H59, Berlin: Springer; 1991. pp. 491–499. 34. Flajnik M F, Kasahara M, Shum B P, Salter-Cid L, Taylor E, Du Pasquier L. EMBO J. 1993;12:4385–4396. [PubMed] 35. Kearney J F, Radbruch A, Liesegang B, Rajewsky K. J Immunol. 1979;123:1548–1550. [PubMed] 36. Roux K H, Greenberg A S, Greene L, Strelets L, Avila D, McKinney E C, Flajnik M F. Proc Natl Acad Sci USA. 1998;95:11804–11809. [PubMed] 37. Hsu E, Du Pasquier L. Mol Immunol. 1984;21:257–270. [PubMed] 38. Frazer J K, Capra J D. In: Fundamental Immunology. 4th Ed. Paul W E, editor. Philadelphia: Lippincott; 1999. pp. pp.37–74. 39. Max E E. In: Fundamental Immunology. 4th Ed. Paul W E, editor. Philadelphia: Lippincott; 1999. pp. 111–182. 40. Marchalonis J J, Schluter S F, Bernstein R M, Shen S, Edmundson A B. Adv Immunol. 1998;70:417–506. [PubMed] 41. Harding F A, Cohen N, Litman G W. Nucleic Acids Res. 1990;18:1015–1020. [PubMed] 42. Rast J P, Amemiya C T, Litman R T, Strong S J, Litman G W. Immunogenetics. 1998;47:234–245. [PubMed] 43. Hohman V S, Schuchman D B, Schluter S F, Marchalonis J J. Proc Natl Acad Sci USA. 1993;90:9882–9886. [PubMed] 44. Anderson M K, Shamblott M J, Litman R T, Litman G W. J Exp Med. 1995;182:109–119. [PubMed] 45. Lee S S, Greenberg A S, Hsu E. Curr Topics Microbiol Immunol. 2000;248:285–300. [PubMed] 46. Alving C R, Wassef N M. Immunol Today. 1999;20:362–366. [PubMed] 47. Guddat L W, Herron J N, Edmundson A B. Proc Natl Acad Sci USA. 1993;90:4271–4275. [PubMed] 48. Poljak R J. Adv Immunol. 1975;21:1–33. [PubMed] 49. Mussmann R, Courtet M, Du Pasquier L. Eur J Immunol. 1998;8:2989–3001. 50. Mouthon L, Lacroix-Desmazes S, Nobrega A, Barreau C, Coutinho A, Kazatchkine M D. Scand J Immunol. 1996;44:243–251. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Science. 1985 Mar 29; 227(4694):1597-601.
[Science. 1985]Proc Natl Acad Sci U S A. 1989 Jul; 86(13):5094-8.
[Proc Natl Acad Sci U S A. 1989]J Exp Med. 1990 Nov 1; 172(5):1377-90.
[J Exp Med. 1990]J Immunol. 1994 May 1; 152(9):4500-7.
[J Immunol. 1994]Ann N Y Acad Sci. 1992 May 4; 651():1-9.
[Ann N Y Acad Sci. 1992]Curr Top Microbiol Immunol. 2000; 248():249-70.
[Curr Top Microbiol Immunol. 2000]J Exp Med. 1965 Sep 1; 122(3):601-18.
[J Exp Med. 1965]Nature. 1995 Mar 9; 374(6518):168-73.
[Nature. 1995]Nucleic Acids Res. 1990 Nov 11; 18(21):6369-76.
[Nucleic Acids Res. 1990]Immunogenetics. 1999 Jan; 49(1):56-67.
[Immunogenetics. 1999]Nature. 1986 Apr 10-16; 320(6062):546-9.
[Nature. 1986]Proc Natl Acad Sci U S A. 1987 Aug; 84(16):5868-72.
[Proc Natl Acad Sci U S A. 1987]EMBO J. 1988 Jul; 7(7):1979-88.
[EMBO J. 1988]EMBO J. 1988 Nov; 7(11):3413-22.
[EMBO J. 1988]J Exp Med. 2000 May 15; 191(10):1631-6.
[J Exp Med. 2000]Cell Tissue Res. 1983; 230(2):337-51.
[Cell Tissue Res. 1983]Proc Natl Acad Sci U S A. 2000 Apr 25; 97(9):4712-7.
[Proc Natl Acad Sci U S A. 2000]J Immunol. 1967 Dec; 99(6):1226-35.
[J Immunol. 1967]J Immunol. 1997 Dec 15; 159(12):6097-104.
[J Immunol. 1997]Mol Immunol. 1992 Sep; 29(9):1157-8.
[Mol Immunol. 1992]Proc Natl Acad Sci U S A. 2000 Apr 25; 97(9):4712-7.
[Proc Natl Acad Sci U S A. 2000]EMBO J. 1993 Nov; 12(11):4385-96.
[EMBO J. 1993]J Immunol. 1997 Dec 15; 159(12):6097-104.
[J Immunol. 1997]Nature. 1995 Mar 9; 374(6518):168-73.
[Nature. 1995]J Immunol. 1979 Oct; 123(4):1548-50.
[J Immunol. 1979]Proc Natl Acad Sci U S A. 1998 Sep 29; 95(20):11804-9.
[Proc Natl Acad Sci U S A. 1998]Mol Immunol. 1984 Apr; 21(4):257-70.
[Mol Immunol. 1984]Eur J Immunol. 1996 May; 26(5):1123-9.
[Eur J Immunol. 1996]Proc Natl Acad Sci U S A. 1998 Sep 29; 95(20):11804-9.
[Proc Natl Acad Sci U S A. 1998]Nature. 1995 Mar 9; 374(6518):168-73.
[Nature. 1995]J Immunol. 1967 Dec; 99(6):1226-35.
[J Immunol. 1967]EMBO J. 1991 Sep; 10(9):2461-70.
[EMBO J. 1991]J Immunol. 1994 May 1; 152(9):4500-7.
[J Immunol. 1994]J Exp Med. 1990 Nov 1; 172(5):1377-90.
[J Exp Med. 1990]EMBO J. 1988 Nov; 7(11):3413-22.
[EMBO J. 1988]EMBO J. 1988 Nov; 7(11):3413-22.
[EMBO J. 1988]Adv Immunol. 1998; 70():417-506.
[Adv Immunol. 1998]Mol Immunol. 1992 Sep; 29(9):1157-8.
[Mol Immunol. 1992]Proc Natl Acad Sci U S A. 1987 Aug; 84(16):5868-72.
[Proc Natl Acad Sci U S A. 1987]EMBO J. 1988 Jul; 7(7):1979-88.
[EMBO J. 1988]Nucleic Acids Res. 1990 Feb 25; 18(4):1015-20.
[Nucleic Acids Res. 1990]EMBO J. 1988 Nov; 7(11):3413-22.
[EMBO J. 1988]Curr Top Microbiol Immunol. 2000; 248():271-82.
[Curr Top Microbiol Immunol. 2000]Immunogenetics. 1998; 47(3):234-45.
[Immunogenetics. 1998]J Exp Med. 2000 May 15; 191(10):1637-48.
[J Exp Med. 2000]J Exp Med. 2000 May 15; 191(10):1631-6.
[J Exp Med. 2000]Curr Top Microbiol Immunol. 2000; 248():271-82.
[Curr Top Microbiol Immunol. 2000]J Exp Med. 2000 May 15; 191(10):1637-48.
[J Exp Med. 2000]Immunol Today. 1999 Aug; 20(8):362-6.
[Immunol Today. 1999]Proc Natl Acad Sci U S A. 1993 May 1; 90(9):4271-5.
[Proc Natl Acad Sci U S A. 1993]Adv Immunol. 1975; 21():1-33.
[Adv Immunol. 1975]Cell Tissue Res. 1983; 230(2):337-51.
[Cell Tissue Res. 1983]Cell. 1989 Dec 22; 59(6):953-4.
[Cell. 1989]Scand J Immunol. 1996 Sep; 44(3):243-51.
[Scand J Immunol. 1996]Eur J Immunol. 1996 May; 26(5):1123-9.
[Eur J Immunol. 1996]EMBO J. 1988 Nov; 7(11):3413-22.
[EMBO J. 1988]Science. 1985 Mar 29; 227(4694):1597-601.
[Science. 1985]Proc Natl Acad Sci U S A. 1989 Jul; 86(13):5094-8.
[Proc Natl Acad Sci U S A. 1989]J Exp Med. 1990 Nov 1; 172(5):1377-90.
[J Exp Med. 1990]